ALK-Abelló (ALK) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
26 Oct, 2026Opening remarks and agenda
Approved the 2023 annual report and discharged the Board of Directors and Board of Management.
Board and executive committee updates
Re-elected Anders Hedegaard as Chair and Lene Skole as Vice Chair.
Re-elected Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of Directors.
Dividend announcements
No ordinary dividend declared in accordance with the approved 2023 annual report.
Partial view of Summaries dataset, powered by Quartr API
Latest events from ALK-Abelló
- No ordinary dividend; Alan Main joined the Board as governance measures were approved.ALK
AGM 2022 - 2022 accounts approved, Board refreshed, and no ordinary dividend declared.ALKAGM 2023
- 15% revenue growth and 65% EBIT increase, with strong outlook and major product launches ahead.ALKQ4 2024
- Q2 2026 saw 18% revenue and 19% EBIT growth, with upgraded full-year outlook.ALKQ2 2026
- 18% revenue and 19% EBIT growth in Q2, with upgraded full-year outlook and strong tablet sales.ALKQ2 2026
- 2025 growth, a DKK 355 million dividend and approved governance changes.ALKAGM 2026
- Record growth, reinvestment, Board re-election and no 2024 dividend.ALKAGM 2025
- Q3 revenue up 18% and EBIT margin at 23%, driven by tablet and JextⓇ sales, with neffyⓇ deal fueling growth.ALKQ3 2024
- Q1 saw 12% revenue growth, 50% EBIT surge, and strong pediatric and neffy® product momentum.ALKQ1 2025